Alayi Tchilabalo Dilezitoko, Van Dorsselaer Alain, Epting Thomas, Bissé Emmanuel, Schaeffer-Reiss Christine
Laboratoire de Spectrométrie de Masse Bio-Organique, Université de Strasbourg, IPHC, CNRS , Strasbourg , France.
Hemoglobin. 2014;38(2):133-6. doi: 10.3109/03630269.2014.880063. Epub 2014 Jan 29.
We report a new slow-moving δ chain hemoglobin (Hb) variant, named Hb A2-Konz [δ50(D1)Ser → Thr; HBD: c.151T > A]. It was detected during simultaneous measurement of Hb A1C and Hb A2 by high resolution cation exchange high performance liquid chromatography (HPLC) using a PolyCATA column. Hb A2-Konz comprised 0.8% of total Hb. This new variant was identified by peptide mapping using nanoliquid chromatography electrospray ionization-tandem mass spectrometry (nanoLC-ESI-MS/MS) as a serine to threonine substitution at δ50(D1), indicating that the variant was due to a single base change at codon 51 (TCT > ACT) of the δ-globin gene. The new mutant is clinically silent but could lead to a misdiagnosis of β-thalassemia (β-thal) based on the level of Hb A2.
我们报告了一种新的慢速移动的δ链血红蛋白(Hb)变异体,命名为Hb A2-Konz [δ50(D1)Ser→Thr;HBD:c.151T>A]。它是在使用PolyCATA柱通过高分辨率阳离子交换高效液相色谱(HPLC)同时测量Hb A1C和Hb A2时检测到的。Hb A2-Konz占总Hb的0.8%。使用纳升液相色谱电喷雾电离串联质谱(nanoLC-ESI-MS/MS)通过肽图谱分析鉴定出这种新变异体为δ50(D1)处丝氨酸到苏氨酸的替代,表明该变异体是由于δ-珠蛋白基因第51密码子(TCT>ACT)的单个碱基变化所致。这种新的突变在临床上无明显症状,但基于Hb A2水平可能导致β地中海贫血(β-thal)的误诊。